Aging Population And Healthcare Spending Will Drive Neuromodulation Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
30 Jul 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$80.00
32.9% undervalued intrinsic discount15 Aug
US$53.72
1Y
16.7%7D
10.0%